Targeted vaccination of teenagers following continued rapid endemic expansion of a single meningococcal group W clone (sequence type 11 clonal complex), United Kingdom 2015

Eurosurveillance

Volumn 20, Issue 28, 2015, Pages

  Campbell, H ^a   Saliba, V ^a   Borrow, R ^a   Ramsay, M ^a   Ladhani, S N ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGITIS VACCINE; BACTERIAL ANTIGEN; MENINGOCOCCUS VACCINE; VACCINE;

ADOLESCENT; ADULT; AGE; ARTICLE; HUMAN; MENINGOCOCCOSIS; UNITED KINGDOM; VACCINATION; AGE DISTRIBUTION; CLASSIFICATION; ENDEMIC DISEASE; EPIDEMIC; EPIDEMIOLOGICAL MONITORING; FEMALE; GENETICS; GREAT BRITAIN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL INFECTIONS; MICROBIOLOGY; NEISSERIA MENINGITIDIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVENTIVE HEALTH SERVICE; PROCEDURES;

ADOLESCENT; AGE DISTRIBUTION; ANTIGENS, BACTERIAL; DISEASE OUTBREAKS; ENDEMIC DISEASES; EPIDEMIOLOGICAL MONITORING; FEMALE; GREAT BRITAIN; HUMANS; IMMUNIZATION PROGRAMS; MALE; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS; PHENOTYPE; POLYMERASE CHAIN REACTION; VACCINATION; VACCINES, CONJUGATE;

EID: 84937685196     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2015.20.28.21188     Document Type: Article

References (14)

1. Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine. 2009;27(Suppl 2):B51-63. http://dx.doi.org/10.1016/j.vaccine.2009.04.063 PMID:19477562
2. European Centre for Disease Prevention and Control. Surveillance of invasive bacterial diseases in Europe, 2011. Stockholm: ECDC; 2013. Available from: http://ecdc.europa. eu/en/publications/Publications/invasive-bacterial-diseasessurveillance- 2011.pdf
3. Campbell H, Andrews N, Borrow R, Trotter C, Miller E. Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity. Clin Vaccine Immunol. 2010;17(5):840-7. http://dx.doi.org/10.1128/CVI.00529-09 PMID:20219881
4. Ladhani SN, Flood JS, Ramsay ME, Campbell H, Gray SJ, Kaczmarski EB, et al. Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines. Vaccine. 2012;30(24):3710-6. http://dx.doi. org/10.1016/j.vaccine.2012.03.011 PMID:22429756
5. Ladhani SN, Beebeejaun K, Lucidarme J, Campbell H, Gray S, Kaczmarski E, et al. Increase in endemic Neisseria meningitidis capsular group W ST-11 complex associated with severe invasive disease in England and Wales. Clin Infect Dis.2015;60(4):578-85.
6. Hahné SJ, Gray SJ, Aguilera JF, Crowcroft NS, Nichols T, et al. W135 meningococcal disease in England and Wales associated with Hajj 2000 and 2001. Lancet. 2002;359(9306):582-3. http://dx.doi.org/10.1016/S0140-6736(02)07716-4 PMID:11867116
7. Abad R, López EL, Debbag R, Vázquez JA. Serogroup W meningococcal disease: global spread and current affect on the Southern Cone in Latin America. Epidemiol Infect. 2014;142(12):2461-70. http://dx.doi.org/10.1017/ S0950268814001149 PMID:24831052
8. Lucidarme J, Hill DM, Bratcher HB, Gray SJ, du Plessis M, Tsang RS, et al. Geo-temporal distribution of distinct strains of the hyperinvasive meningococcal ST-11 clonal complex. J Infect. 2015. Forthcoming.
9. Araya P, Fernández J, Del Canto F, Seoane M, Ibarz-Pavón AB, Barra G, et al. Neisseria meningitidis ST-11 clonal complex, Chile 2012. Emerg Infect Dis. 2015;21(2):339-41. http://dx.doi. org/10.3201/eid2102.140746 PMID:25625322
10. Public Health England (PHE). The Joint Committee on Vaccination and Immunisation (JCVI). The JCVI has today (13 March 2015) advised that immunisation for meningococcal group W (MenW) disease be offered to 14 to 18 year-olds. 2015 Mar 13. Press release. Available from: https://www. gov.uk/government/news/meningococcal-group-w-menwimmunisation- advised-for-14-to-18-year-olds
11. Jeppesen CA, Snape MD, Robinson H, Gossger N, John TM, Voysey M, et al. Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy. J Infect. 2015;71(1):43-52. http://dx.doi.org/10.1016/j. jinf.2015.02.006 PMID:25709085
12. Christensen H, May M, Bowen L, Hickman M, Trotter CL. Meningococcal carriage by age: a systematic review and metaanalysis. Lancet Infect Dis. 2010;10(12):853-61. http://dx.doi. org/10.1016/S1473-3099(10)70251-6 PMID:21075057
13. Public Health England (PHE). Immunisation information for health professionals and immunisation practitioners. London: PHE; 2013. Available from: https://www.gov.uk/government/ collections/immunisation.
14. Taha MK, Kacou-N'douba A, Hong E, Deghmane AE, Giorgini D, Okpo SL, et al. Travel-related Neisseria meningitidis serogroup W135 infection, France. Emerg Infect Dis. 2013;19(6):1030-2. http://dx.doi.org/10.3201/eid1906.120515 PMID:23735310